NCT04186078 Clinical Characteristics of Patients With Sleep Apnea in Korea
| NCT ID | NCT04186078 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Sleep Apnea Syndromes |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2019-11-11 |
| Primary Completion | 2045-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2019-11-11 with a primary completion date of 2045-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sleep-disordered breathing including obstructive sleep apnea (OSA) is an extremely common medical disorder associated with important morbidity. The purpose of this study is to understand the clinical features and course of patients with sleep apnea in Korea. Participants who are suspected of sleep apnea due to symptoms such as snoring, witnessed apneas, waking up with a choking sensation, excessive sleepiness, non-restorative sleep, difficulty initiating or maintaining sleep, fatigue or tiredness, and morning headache will be prospectively recruited at the outpatient clinic of Seoul National University Hospital. After polysomnography (PSG) or respiratory polygraphy, patients with sleep apnea including OSA and central sleep apnea (CSA) will be followed regularly. Participants not having sleep apnea (apnea-hypopnea index \< 5/hour) will only have a baseline visit. For only participants with the informed consent of donating blood, their blood samples will be collected and stored in the Seoul National University Hospital-Human Biobank (SNUH-HUB).
Eligibility Criteria
Inclusion Criteria: * Participants who are suspected of sleep apnea due to symptoms such as snoring, witnessed apneas, waking up with a choking sensation, excessive sleepiness, non-restorative sleep, difficulty initiating or maintaining sleep, fatigue or tiredness, and morning headache Exclusion Criteria: * None
Contact & Investigator
Jaeyoung Cho, M.D.
PRINCIPAL INVESTIGATOR
Seoul National University Hospital
Frequently Asked Questions
Who can join the NCT04186078 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Sleep Apnea Syndromes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04186078 currently recruiting?
Yes, NCT04186078 is actively recruiting participants. Contact the research team at apricot6@snu.ac.kr for enrollment information.
Where is the NCT04186078 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT04186078 clinical trial?
NCT04186078 is sponsored by Seoul National University Hospital. The principal investigator is Jaeyoung Cho, M.D. at Seoul National University Hospital. The trial plans to enroll 1,000 participants.